17 Aug 2016
Pharmac called on to improve funding practices
Melanoma sufferers who missed out on Keytruda, now funded by Pharmac, are still paying the price, a parliamentary select committee has been told.
Melanoma sufferers who missed out on Keytruda, now funded by Pharmac, are still paying the price, a parliamentary select committee has been told.